EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS037-16135 
Organism
Homo sapiens 
Tissue/cell
ESC 
Coordinate
chr17:80290450-80291500 
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
MAFGMA0659.1chr17:80290883-80290904TTACTGCGGAGTCAGCAAAAC-6.39
MAFGMA0659.1chr17:80290883-80290904TTACTGCGGAGTCAGCAAAAC+6.53
MAFKMA0496.2chr17:80290884-80290903TACTGCGGAGTCAGCAAAA+6.56
MAFKMA0496.2chr17:80290884-80290903TACTGCGGAGTCAGCAAAA-6
MyogMA0500.1chr17:80290481-80290492GACAGCTGCAG+6.62
Tcf12MA0521.1chr17:80290481-80290492GACAGCTGCAG+6.14
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_40455chr17:80289885-80291329K562
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr178029080280291044
Enhancer Sequence
CCGAGAATGA GCACACCAAC ACCTCTCAGA AGACAGCTGC AGCCTGCAGA GGCCATGGAC 60
CCCACCCAGG CCCACGGTGT GGACGGCTCT GCCCTGGTCT CTGCTGAGCC AGGCCCAGAG 120
GGGACCCCAG GTGAGCAGCA AAGCCCCCCA GGCCTGGGGC TAGACCGGGC TAACCCTTCC 180
TGCTCAGCAC CTGTTCACCT GTCCCCTCTG CTGGTGGCCT CCTGTCCTCC CGCTCTGGGC 240
TCAGCAGCAG CCCCGTGGAG AGGCCCTGCC ACCACCCCCG CCCTGCTGGA GACAGGCCTC 300
CTACGCGGGC TCCTGCAGCC GGTCGCCCTG GGCCTCCTAG AAGCCGGGGA TCCTCTGCTG 360
ACCACCGGCA GAAAACGTGC TTCTCAAGCT GCAGGTGATT CACCAGTAGT GGGCAAGGAA 420
CTGAATGTGG TGATTACTGC GGAGTCAGCA AAACCCGCGT GAGAACGGGC AGCTGAGGGC 480
CTGCCGGGTG AGGGAAGCCT CACGGTTCCT GTTTCATGAG TTTGCTGTGA GTGCACACGA 540
GGCTGTGGCT GTGGAGTGTG CAACAGTCCA CGCGTGCCTG CGTGTGCTCA TGTGCGTGTG 600
TCCACCAGCT TGTGTGCACG CATATGAGCG AGTGCGTTTT GCTCCCAGCT TGGTCGCAGC 660
GACGGCGCAG GGAACCCCGG GTGAGGCCGA GGACCGGGAA GGGAGGAGGG GGCTCCGACC 720
CATCGGACTT AGGGGAGCCC CGGGTCCGAG ACGCCGCCTC TGTCCCTTCA AGAGTCGAGC 780
CTGGCGCACA GGGCAGGGAC GCGGGTCCCC ACACCGGCCG GCAGCTCGTT CCCGCCCATA 840
CTCGGGTACG CCCGCTGCGA CCCCGCCCGC CTGGCCTGCG ACGCACGCTC AGGGCCAGCG 900
GGGGGTGACG GTCCCAGAGG CAGAGGCGCC GCAGCCCCAG AGTCCCCATC CCTGCGCGGA 960
CCGGCAACCC CAGTGCACCA AGAGGCCCTA ACACCGAGCC CCCAGCACCG AGTCCCCAGC 1020
ACCGGGCCCT CAGCACCGAG TCCCCAGCAC 1050